One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1002/hon.3163_t06
Copy DOI Journal: Hematological oncology |  Publication Date: Jun 1, 2023 |
Affiliation: The University of Texas MD Anderson Cancer Center, Gilead Sciences (United States), Helios Hospital Berlin-Buch, University of Melbourne, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Fred Hutch Cancer Center, Dana-Farber Cancer Institute, Centre Hospitalier Universitaire de Lille, University of Lille, Colorado Blood Cancer Institute, Institut Català d'Oncologia, Amsterdam University Medical Centers, NIHR CRUK Experimental Cancer Medicine Centre, University of Southampton, Moffitt Cancer Center, Sarah CannonZUMA‐23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE AS FIRST‐LINE THERAPY IN PATIENTS WITH HIGH‐RISK LARGE B‐CELL LYMPHOMA
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
